Pregabalin a back pain killer drug is no more effective than a placebo. Patients whom are prescribed this drug for Sciatica which is back and leg pain, have not found this beneficial. A new clinical trial claims that this drug is no better than a placebo.
A study published in New England Journal of Medicine claims that a placebo is just as effective as Pregabalin. This study was based upon over two hundred patients. These patients were randomly assigned to take either a placebo or capsule of Pregabalin over a course of eight weeks.
Starting dosage was one hundred fifty milligrams per day and increased to six hundred milligrams per day. Patients taking Pregabalin received more side affects. One common side affect was dizziness.
Pregabalin is marketed and trademarked as Lyrica. This was a double blind study. Two hundred nine patients participated.
A scale of one to ten was used to measure severity of back pain. One hundred eight patients received Pregabalin, while one hundred and one received a placebo. Two patients taking Pregabalin were excluded from this study.